Patents by Inventor ANDREW ORRY

ANDREW ORRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043424
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Application
    Filed: September 12, 2023
    Publication date: February 8, 2024
    Applicant: Eil Therapeutics, Inc.
    Inventors: Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Ruben Abagyan, Andrew Orry, Polo Chun-Hung Lam, Nikolay Savchuk
  • Patent number: 11834450
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: December 5, 2023
    Assignee: EIL THERAPEUTICS, INC.
    Inventors: Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Ruben Abagyan, Andrew Orry, Polo Chun-Hung Lam, Nikolay Savchuk
  • Publication number: 20230357238
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (A):
    Type: Application
    Filed: July 14, 2023
    Publication date: November 9, 2023
    Applicant: Eil Therapeutics, Inc.
    Inventors: Volodymyr KYSIL, Vladislav Zenonovich PARCHINSKY, Alexei PUSHECHNIKOV, Alexandre Vasilievich IVACHTCHENKO, Ruben ABAGYAN, Andrew ORRY, Polo Chun-Hung LAM, Nikolay SAVCHUK
  • Patent number: 11697650
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: July 11, 2023
    Assignee: Eil Therapeutics, Inc.
    Inventors: Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Ruben Abagyan, Andrew Orry, Polo Chun-Hung Lam, Nikolay Savchuk
  • Publication number: 20220306625
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Application
    Filed: March 18, 2022
    Publication date: September 29, 2022
    Inventors: Volodymyr KYSIL, Vladislav Zenonovich PARCHINSKY, Alexei PUSHECHNIKOV, Alexandre Vasilievich IVACHTCHENKO, Ruben ABAGYAN, Andrew ORRY, Polo Chun-Hung LAM, Nikolay SAVCHUK
  • Publication number: 20220289745
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Application
    Filed: March 11, 2022
    Publication date: September 15, 2022
    Inventors: Volodymyr KYSIL, Vladislav Zenonovich PARCHINSKY, Alexei PUSHECHNIKOV, Alexandre Vasilievich IVACHTCHENKO, Ruben ABAGYAN, Andrew ORRY, Polo Chun-Hung LAM, Nikolay SAVCHUK
  • Publication number: 20070016853
    Abstract: A structured document file which includes graphical and non graphical information. The graphical information includes the vector and coordinate description of a representation of at least one three dimensional object and at least one of the following group of view attributes or features: rotation, translation, view angle, lighting, colors, specific graphical representations, labels and parameters. The vector and coordinate description are stored with or independently from the one or more view attributes or features and the vector and coordinate description and the one or more view attributes are stored in a single file which can be accessed and viewed by a structured document viewer. Related authoring tools and viewers are also disclosed.
    Type: Application
    Filed: July 14, 2006
    Publication date: January 18, 2007
    Applicant: MOLSOFT, LLC
    Inventors: Ruben ABAGYAN, EUGENE RAUSH, MAXIM TOTROV, LEVON BUDAGYAN, ANDREW ORRY